CALIDI BIOTHERAPEUTICS INC has a total of 16 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BIONDVAX PHARMACEUTICALS LTD, SILLAJEN INC and HOOKIPA BIOTECH GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Enzymes | |
#7 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Draganov Dobrin | 8 |
#2 | Szalay Aladar | 8 |
#3 | Minev Boris | 7 |
#4 | Szalay Aladar A | 5 |
#5 | Fernandez Santidrian Antonio | 2 |
#6 | Nguyen Duong | 1 |
#7 | Nguyen Duong Hoang | 1 |
Publication | Filing date | Title |
---|---|---|
US2020140824A1 | Enhanced systems for cell-mediated oncolytic viral therapy | |
US2019367880A1 | Cell-based vehicles for potentiation of viral therapy | |
AU2019282239A1 | Cell-based vehicles for potentiation of viral therapy | |
AU2015335607A1 | Combination immunotherapy approach for treatment of cancer |